secwatch.observer — SEC 8-K summary
======================================

Issuer:     APTARGROUP, INC. (ATR)
CIK:        0000896622
Form:       8-K
Filed at:   2026-03-17T23:59:59+00:00
Accession:  0001104659-26-029612
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AptarGroup CEO Stephan Tanda to retire Sept 1, 2026; Gael Touya appointed successor
--------------------------------------------------------------------------------

- CEO Tanda to retire effective Sep 1, 2026; will serve as strategic advisor through Dec 31, 2026 and remain on Board until year-end.
- Gael Touya, currently president of Aptar Pharma, named President & CEO effective Sep 1, 2026; also to join Board.
- Touya employment agreement: base salary $1,060,000, target bonus 120%, LTI target 500% of base salary; €2.5M deferred compensation payout.
- Retention equity awards: CFO Vanessa Kanu receives $1.3M in RSUs (3-year cliff); Closures president Hedi Tlili receives $1.3M (2-year cliff).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/896622/000110465926029612/0001104659-26-029612-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/896622/000110465926029612/tm268924d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-029612

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer